De Rubertis Francesco
SEC insider (Form 3/4/5 filer). CIK 0001601521. Director at Centessa Pharmaceuticals plc (CNTA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in CHESHIRE.
Companies De Rubertis Francesco has filed insider reports for
- Centessa Pharmaceuticals plc (CNTA): Director
De Rubertis Francesco
CIK: 0001601521
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Centessa Pharmaceuticals plc
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect4.4M shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect55.7K shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect3.9M shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect93.5K shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect11.2M shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect281.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition | 4,398,519 | - | $0 | Indirect |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition | 55,677 | - | $0 | Indirect |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition | 3,936,970 | - | $0 | Indirect |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition | 93,526 | - | $0 | Indirect |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition | 11,197,303 | - | $0 | Indirect |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition | 281,162 | - | $0 | Indirect |
1-6 of 6 transactions